Unknown PHASE2 INTERVENTIONAL 2-arm NCT00840359

Study of the Efficacy of Daylight Activated Photodynamic Therapy in the Treatment of Cutaneous Leishmaniasis

Phase 2 Study of the Efficacy of Daylight Activated Photodynamic Therapy in the Treatment of Cutaneous Leishmaniasis

Sponsor: Hadassah Medical Organization

Interventions Cryotherapy Photodynamic therapy

Updated 7 times since 2017 Last updated: Aug 15, 2011 Started: Sep 30, 2009 Primary completion: Oct 31, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00840359, this PHASE2 trial focuses on Cutaneous Leishmaniasis and remains ongoing. Sponsored by Hadassah Medical Organization, it has been updated 7 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Unknown PHASE2
Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

Status: Enrolling By Invitation → Unknown Status
Jan 2017 — Feb 2017 [monthly]

Enrolling By Invitation PHASE2

First recorded

Sep 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hadassah Medical Organization

Data source: Hadassah Medical Organization

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jerusalem, Israel